Kv1.3 channel as a promising therapeutic target for acquired aplastic anemia.
D000741:Anemia, Aplastic / Q000188:drug therapy*; D001172:Arthritis, Rheumatoid / Q000628:therapy; D001324:Autoantigens / Q000737:chemistry; D001327:Autoimmune Diseases / Q000276:immunology; D002118:Calcium / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000628:therapy; D006801:Humans; D051664:Kv1.3 Potassium Channel / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism; D008954:Models, Biological; D008962:Models, Theoretical; D009103:Multiple Sclerosis / Q000628:therapy; D010641:Phenotype; D013601:T-Lymphocytes / Q000378:metabolism; D016896:Treatment Outcome
D001324:Autoantigens; D051664:Kv1.3 Potassium Channel; D002118:Calcium